Imidazolyl alkyl guanidine derivatives, processes for their preparation
申请人:Heumann Pharma GmbH & Co.
公开号:US05021431A1
公开(公告)日:1991-06-04
New imidazolylalkyl-guanidine derivatives are described, which by virtue of their agonistic action on histamine-H.sub.2 receptors and in part also due to their additional H.sub.1 -antagonistic receptor activity can be used in the treatment of cardiac diseases, certain forms of hypertension and diseases of arterial occlusion. These imidazolylalkyl-guanidine derivatives correspond to the general formula I: ##STR1##